FDA Inspection 1125536 — Seratec SAS
The FDA completed an inspection of Seratec SAS on Oct 19, 2017 in Courville Sur Eure. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 19, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Courville Sur Eure (France)
Additional Details
Mutual Recognition Agreement (MRA)